Bogar, F. Et Al. 2023. Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers. CANCER BIOMARKERS , vol.38, no.1 , 111-120.

Bogar, F., Ak, G., Metintas, S., Ayhanci, A., & Metintas, M., (2023). Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers. CANCER BIOMARKERS , vol.38, no.1, 111-120.

Bogar, Filiz Et Al. "Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers," CANCER BIOMARKERS , vol.38, no.1, 111-120, 2023

Bogar, Filiz Et Al. "Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers." CANCER BIOMARKERS , vol.38, no.1, pp.111-120, 2023

Bogar, F. Et Al. (2023) . "Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers." CANCER BIOMARKERS , vol.38, no.1, pp.111-120.

@article{article, author={Filiz Bogar Et Al. }, title={Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers}, journal={CANCER BIOMARKERS}, year=2023, pages={111-120} }